Navigation Links
Stem Cell Product Commercialization Focus of Summit
Date:1/7/2009

PHILADELPHIA, Jan. 7 /PRNewswire/ -- RRY Publications announced that the 4th Annual Stem Cell Summit, the premier gathering of stem cell company executives, scientists and investors, will focus on commercialization of stem cell therapies. The Summit is an intensive one-day event where attendees explore the therapeutic applications of adult and embryonic stem cells, the successful path to stem cell product commercialization, and the latest investment opportunities in this space.

The 4th Annual Stem Cell Summit features 35 corporate presenters, keynote speaker Dr. Arnold Caplan, Ph.D., and a scientific panel discussion. It will take place on February 17, 2009, at Bridgewaters in New York City's historic South Street Seaport.

Confirmed presenting stem cell companies include:

    3DM, Inc.                                 Incell Corporation, LLC
    Aastrom Biosciences, Inc.                 MaxCyte, Inc.
    Aldagen, Inc.                             Moraga Biotechnology Corporation
    AllCells, LLC                             Neuronyx, Inc.
    Arteriocyte, Inc.                         Novocell, Inc.
    ArunA Biomedical, Inc.                    NuVasive, Inc.
    BioE Corp.                                Osiris Therapeutics, Inc.
    California Stem Cell, Inc.                Progenitor Cell Therapy, Inc.
    Cellerix, S.A.                            SpineSmith, LP
    Cognate BioServices, Inc.                 Stemagen
    Cytori Therapeutics, Inc.                 Stematix, Inc.
    Gamida Cell Ltd.                          Stemina, Inc.
    Geron Corp.                               TiGenix NV
    Harvest Technologies Corp.                Tissue Genesis, Inc.
    Histogen, Inc.                            Vet-Stem, Inc.
    Histogenics Corporation


In addition to the company and product overviews, Robin R. Young, CFA, the leading medical technologies analyst in the United States with over 25 years of experience in the cardiovascular, orthopedic and biomaterials industries, will update his 10-year market forecast for the stem cell industry.

"2008 was a record-breaking year for stem cell technologies with three of the largest stem cell transactions ever recorded?one for more than $1 billion for distribution rights, another for $200 million from the U.S. government, and yet another for $85 million to purchase a single stem cell product line," said Young. "It is, therefore, possible that 2009 will be the year that stem cell companies and technologies cross the $100 million annual revenue line and become a billion-dollar-valuation industry."

4th Annual Stem Cell Summit Facts

    What:          2009's Premier Gathering of Stem Cell Company Executives,
                   Scientists and Investors
    When:          February 17, 2009
    Where:         Bridgewaters
                   11 Fulton Street
                   New York City
    Admission:     $1,200 advance registration (December 1, 2008 - January 31,
                   2009)
                   $1,500 (February 1 - 17, 2009)
    Information:   For presentation or sponsorship opportunities, contact Lisa
                   Carpenter at 877-817-6450 or lisa@ryortho.com. Additional
                   information, including registration details, is available
                   at www.stemcellsummit.com
           

    Contacts:       Lisa Carpenter
                    RRY Publications, LLC
                    877-817-6450
                    lisa@ryortho.com


'/>"/>
SOURCE RRY Publications
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
3. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
4. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
5. End-to-End HR Performance Benchmarks: Metrics That Will Help Turn the HR Cost Center into a Productivity Driver
6. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
7. Drug Detection Kits Manufactured By IDenta Corp. Shown During French Television Broadcast (at TF1) - Product Aids French Police In Bust of 600 Kilograms Of Cocaine
8. Why Are Most Health & Wellness Products Doomed to Failure?
9. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
10. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
11. OneBeacon Professional Partners to Offer Podiatrist Medical Malpractice Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/24/2017)... , ... August 24, 2017 , ... ... Sept. 6, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/observationalresearch      ... bring drugs to market sooner by letting drugmakers substitute observational data and in ...
(Date:8/24/2017)... Angeles, CA (PRWEB) , ... August 24, 2017 ... ... discharged from hospitals who are not fully recovered, or have a condition that ... who has a chronic condition that needs monitoring until stable, such as diabetes, ...
(Date:8/23/2017)... Jose, California (PRWEB) , ... August 23, 2017 , ... ... San Jose, California, office at 1530 The Alameda, Suite 115. The office is located ... has changed, the contact information remains the same. Clients can still call the office ...
(Date:8/23/2017)... , ... August 23, 2017 , ... ... continues to prove the safety and efficacy of HBOT in treating and helping ... the US, points to research showing the similarities of the wounds to the ...
(Date:8/23/2017)... Lauderdale, FL (PRWEB) , ... August 23, 2017 ... ... firms for traveling medical professionals, recently launched a new website, http://www.cirrusmedicalstaffing.com . ... built to respond to the needs of healthcare professionals who are traveling on ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... (NYSE: DPLO), the nation,s largest independent specialty pharmacy, announced financial ... unless otherwise noted, are to the quarter ended June 30, ... 2017 Highlights include: Revenue of $1,126 ... Total prescriptions dispensed of 220,000, compared to 241,000 ... Gross profit per prescription dispensed of $371, ...
(Date:8/4/2017)... , Aug. 4, 2017 The search ... shortly after a physician/patient consult has long been the ... was a notable focus of the largest meeting of ... according to healthcare market research firm Kalorama Information.  The ... testing (POCT) offerings or related supplies and software were ...
(Date:8/3/2017)... Aug. 3, 2017  Opioid addiction and other drugs ... healthcare costs and threatening outcomes, were problems taken on ... IVD industry that support them, met this week. This ... said that drugs of abuse, procalcitonin and acute kidney ... the organization,s 69th meeting in San Diego, ...
Breaking Medicine Technology: